nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—ABCB1—Mitomycin—stomach cancer	0.333	0.483	CbGbCtD
Linagliptin—ABCB1—Irinotecan—stomach cancer	0.0855	0.124	CbGbCtD
Linagliptin—ABCB1—Docetaxel—stomach cancer	0.0626	0.0908	CbGbCtD
Linagliptin—CYP3A4—Irinotecan—stomach cancer	0.0512	0.0742	CbGbCtD
Linagliptin—ABCB1—Doxorubicin—stomach cancer	0.0467	0.0677	CbGbCtD
Linagliptin—ABCB1—Methotrexate—stomach cancer	0.0452	0.0656	CbGbCtD
Linagliptin—CYP3A4—Docetaxel—stomach cancer	0.0375	0.0544	CbGbCtD
Linagliptin—CYP3A4—Doxorubicin—stomach cancer	0.028	0.0406	CbGbCtD
Linagliptin—DPP4—blood vessel—stomach cancer	0.012	0.159	CbGeAlD
Linagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CDX2—stomach cancer	0.00944	0.121	CbGpPWpGaD
Linagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CDX2—stomach cancer	0.00839	0.107	CbGpPWpGaD
Linagliptin—DPP4—Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)—PAX6—stomach cancer	0.00746	0.0953	CbGpPWpGaD
Linagliptin—DPP4—hematopoietic system—stomach cancer	0.00641	0.0847	CbGeAlD
Linagliptin—DPP4—epithelium—stomach cancer	0.00586	0.0774	CbGeAlD
Linagliptin—DPP4—smooth muscle tissue—stomach cancer	0.00565	0.0746	CbGeAlD
Linagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—PAX6—stomach cancer	0.0055	0.0704	CbGpPWpGaD
Linagliptin—DPP4—pancreas—stomach cancer	0.00522	0.069	CbGeAlD
Linagliptin—Bronchial hyperreactivity—Methotrexate—stomach cancer	0.00498	0.0318	CcSEcCtD
Linagliptin—DPP4—Incretin synthesis, secretion, and inactivation—PAX6—stomach cancer	0.00489	0.0626	CbGpPWpGaD
Linagliptin—DPP4—lymphoid tissue—stomach cancer	0.00451	0.0596	CbGeAlD
Linagliptin—DPP4—digestive system—stomach cancer	0.00446	0.0589	CbGeAlD
Linagliptin—DPP4—bone marrow—stomach cancer	0.00411	0.0543	CbGeAlD
Linagliptin—Diabetic—Methotrexate—stomach cancer	0.00389	0.0249	CcSEcCtD
Linagliptin—DPP4—endocrine gland—stomach cancer	0.00368	0.0487	CbGeAlD
Linagliptin—DPP4—liver—stomach cancer	0.00332	0.0439	CbGeAlD
Linagliptin—Hypertriglyceridaemia—Capecitabine—stomach cancer	0.00304	0.0194	CcSEcCtD
Linagliptin—DPP4—Peptide hormone metabolism—CDX2—stomach cancer	0.00285	0.0364	CbGpPWpGaD
Linagliptin—ABCB1—blood vessel—stomach cancer	0.00278	0.0367	CbGeAlD
Linagliptin—Anaphylactic shock—Floxuridine—stomach cancer	0.00273	0.0175	CcSEcCtD
Linagliptin—Infection—Floxuridine—stomach cancer	0.00271	0.0173	CcSEcCtD
Linagliptin—Blood triglycerides increased—Capecitabine—stomach cancer	0.00266	0.017	CcSEcCtD
Linagliptin—DPP4—lymph node—stomach cancer	0.00255	0.0336	CbGeAlD
Linagliptin—Cough—Mitomycin—stomach cancer	0.00229	0.0146	CcSEcCtD
Linagliptin—CYP3A4—hematopoietic system—stomach cancer	0.00209	0.0276	CbGeAlD
Linagliptin—Hypersensitivity—Floxuridine—stomach cancer	0.00201	0.0129	CcSEcCtD
Linagliptin—Diarrhoea—Floxuridine—stomach cancer	0.00187	0.0119	CcSEcCtD
Linagliptin—Rash—Floxuridine—stomach cancer	0.00172	0.011	CcSEcCtD
Linagliptin—Skin exfoliation—Docetaxel—stomach cancer	0.00172	0.011	CcSEcCtD
Linagliptin—Dermatitis—Floxuridine—stomach cancer	0.00172	0.011	CcSEcCtD
Linagliptin—Headache—Floxuridine—stomach cancer	0.00171	0.0109	CcSEcCtD
Linagliptin—Hyperlipidaemia—Epirubicin—stomach cancer	0.00169	0.0108	CcSEcCtD
Linagliptin—Skin exfoliation—Capecitabine—stomach cancer	0.00167	0.0107	CcSEcCtD
Linagliptin—DPP4—Peptide hormone metabolism—PAX6—stomach cancer	0.00166	0.0212	CbGpPWpGaD
Linagliptin—Nasopharyngitis—Fluorouracil—stomach cancer	0.00162	0.0104	CcSEcCtD
Linagliptin—Pancreatitis—Irinotecan—stomach cancer	0.0016	0.0103	CcSEcCtD
Linagliptin—Hyperlipidaemia—Doxorubicin—stomach cancer	0.00156	0.00998	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Irinotecan—stomach cancer	0.00152	0.00973	CcSEcCtD
Linagliptin—ABCB1—hematopoietic system—stomach cancer	0.00148	0.0195	CbGeAlD
Linagliptin—DPP4—Peptide hormone metabolism—ACE—stomach cancer	0.00147	0.0188	CbGpPWpGaD
Linagliptin—Diarrhoea—Mitomycin—stomach cancer	0.00147	0.00937	CcSEcCtD
Linagliptin—Diabetes mellitus—Capecitabine—stomach cancer	0.00146	0.00932	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.00146	0.00931	CcSEcCtD
Linagliptin—CYP3A4—digestive system—stomach cancer	0.00145	0.0192	CbGeAlD
Linagliptin—Infestation NOS—Fluorouracil—stomach cancer	0.0014	0.00894	CcSEcCtD
Linagliptin—Infestation—Fluorouracil—stomach cancer	0.0014	0.00894	CcSEcCtD
Linagliptin—Urinary tract infection—Fluorouracil—stomach cancer	0.00136	0.00869	CcSEcCtD
Linagliptin—ABCB1—epithelium—stomach cancer	0.00135	0.0179	CbGeAlD
Linagliptin—Rash—Mitomycin—stomach cancer	0.00135	0.00864	CcSEcCtD
Linagliptin—Dermatitis—Mitomycin—stomach cancer	0.00135	0.00863	CcSEcCtD
Linagliptin—Headache—Mitomycin—stomach cancer	0.00134	0.00858	CcSEcCtD
Linagliptin—Pain in extremity—Docetaxel—stomach cancer	0.00131	0.00837	CcSEcCtD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.00127	0.0162	CbGpPWpGaD
Linagliptin—Pain in extremity—Capecitabine—stomach cancer	0.00127	0.0081	CcSEcCtD
Linagliptin—Skin exfoliation—Methotrexate—stomach cancer	0.00124	0.00793	CcSEcCtD
Linagliptin—ABCB1—pancreas—stomach cancer	0.0012	0.0159	CbGeAlD
Linagliptin—CYP3A4—endocrine gland—stomach cancer	0.0012	0.0159	CbGeAlD
Linagliptin—Immune system disorder—Irinotecan—stomach cancer	0.00118	0.00757	CcSEcCtD
Linagliptin—Mediastinal disorder—Irinotecan—stomach cancer	0.00118	0.00755	CcSEcCtD
Linagliptin—Nasopharyngitis—Docetaxel—stomach cancer	0.00117	0.00748	CcSEcCtD
Linagliptin—Skin exfoliation—Epirubicin—stomach cancer	0.00116	0.00742	CcSEcCtD
Linagliptin—Nasopharyngitis—Capecitabine—stomach cancer	0.00113	0.00725	CcSEcCtD
Linagliptin—Back pain—Irinotecan—stomach cancer	0.0011	0.00705	CcSEcCtD
Linagliptin—Diabetes mellitus—Methotrexate—stomach cancer	0.00108	0.00693	CcSEcCtD
Linagliptin—CYP3A4—liver—stomach cancer	0.00108	0.0143	CbGeAlD
Linagliptin—Skin exfoliation—Doxorubicin—stomach cancer	0.00107	0.00687	CcSEcCtD
Linagliptin—ABCB1—lymphoid tissue—stomach cancer	0.00104	0.0138	CbGeAlD
Linagliptin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	0.00104	0.0133	CbGpPWpGaD
Linagliptin—Weight increased—Docetaxel—stomach cancer	0.00103	0.00658	CcSEcCtD
Linagliptin—ABCB1—digestive system—stomach cancer	0.00103	0.0136	CbGeAlD
Linagliptin—DPP4—Metabolism of proteins—NOP56—stomach cancer	0.00102	0.0131	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—DPAGT1—stomach cancer	0.00102	0.0131	CbGpPWpGaD
Linagliptin—Upper respiratory tract infection—Capecitabine—stomach cancer	0.00102	0.00651	CcSEcCtD
Linagliptin—Diabetes mellitus—Epirubicin—stomach cancer	0.00101	0.00649	CcSEcCtD
Linagliptin—Infestation NOS—Docetaxel—stomach cancer	0.00101	0.00645	CcSEcCtD
Linagliptin—Infestation—Docetaxel—stomach cancer	0.00101	0.00645	CcSEcCtD
Linagliptin—Weight increased—Capecitabine—stomach cancer	0.000997	0.00637	CcSEcCtD
Linagliptin—Cough—Irinotecan—stomach cancer	0.000995	0.00636	CcSEcCtD
Linagliptin—Infestation NOS—Capecitabine—stomach cancer	0.000976	0.00624	CcSEcCtD
Linagliptin—Infestation—Capecitabine—stomach cancer	0.000976	0.00624	CcSEcCtD
Linagliptin—Urinary tract infection—Capecitabine—stomach cancer	0.000949	0.00607	CcSEcCtD
Linagliptin—ABCB1—bone marrow—stomach cancer	0.000948	0.0125	CbGeAlD
Linagliptin—Diabetes mellitus—Doxorubicin—stomach cancer	0.000939	0.006	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—EEF1A2—stomach cancer	0.000936	0.012	CbGpPWpGaD
Linagliptin—Anaphylactic shock—Irinotecan—stomach cancer	0.000931	0.00595	CcSEcCtD
Linagliptin—Myalgia—Fluorouracil—stomach cancer	0.00093	0.00594	CcSEcCtD
Linagliptin—Infection—Irinotecan—stomach cancer	0.000924	0.00591	CcSEcCtD
Linagliptin—Hypoglycaemia—Epirubicin—stomach cancer	0.000905	0.00578	CcSEcCtD
Linagliptin—Anaphylactic shock—Fluorouracil—stomach cancer	0.000891	0.0057	CcSEcCtD
Linagliptin—Infection—Fluorouracil—stomach cancer	0.000885	0.00566	CcSEcCtD
Linagliptin—Pain in extremity—Epirubicin—stomach cancer	0.000883	0.00564	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—MUC6—stomach cancer	0.00087	0.0111	CbGpPWpGaD
Linagliptin—ABCB1—endocrine gland—stomach cancer	0.00085	0.0112	CbGeAlD
Linagliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.00084	0.0107	CbGpPWpGaD
Linagliptin—Hypoglycaemia—Doxorubicin—stomach cancer	0.000837	0.00535	CcSEcCtD
Linagliptin—Immune system disorder—Docetaxel—stomach cancer	0.000818	0.00523	CcSEcCtD
Linagliptin—Pain in extremity—Doxorubicin—stomach cancer	0.000817	0.00522	CcSEcCtD
Linagliptin—Mediastinal disorder—Docetaxel—stomach cancer	0.000816	0.00522	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000812	0.00519	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000803	0.00514	CcSEcCtD
Linagliptin—Pancreatitis—Methotrexate—stomach cancer	0.000799	0.00511	CcSEcCtD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—BNIP3—stomach cancer	0.000799	0.0102	CbGpPWpGaD
Linagliptin—Constipation—Irinotecan—stomach cancer	0.000796	0.00509	CcSEcCtD
Linagliptin—Immune system disorder—Capecitabine—stomach cancer	0.000792	0.00506	CcSEcCtD
Linagliptin—Mediastinal disorder—Capecitabine—stomach cancer	0.00079	0.00505	CcSEcCtD
Linagliptin—Nasopharyngitis—Epirubicin—stomach cancer	0.000789	0.00505	CcSEcCtD
Linagliptin—Malnutrition—Docetaxel—stomach cancer	0.000788	0.00504	CcSEcCtD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.000783	0.01	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—CCT7—stomach cancer	0.000775	0.00991	CbGpPWpGaD
Linagliptin—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000769	0.00492	CcSEcCtD
Linagliptin—ABCB1—liver—stomach cancer	0.000767	0.0101	CbGeAlD
Linagliptin—Malnutrition—Capecitabine—stomach cancer	0.000763	0.00488	CcSEcCtD
Linagliptin—Back pain—Docetaxel—stomach cancer	0.000762	0.00488	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000758	0.00485	CcSEcCtD
Linagliptin—Pancreatitis—Epirubicin—stomach cancer	0.000748	0.00478	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—EEF1A1—stomach cancer	0.00074	0.00946	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—TUBA1C—stomach cancer	0.00074	0.00946	CbGpPWpGaD
Linagliptin—Back pain—Capecitabine—stomach cancer	0.000738	0.00472	CcSEcCtD
Linagliptin—Nasopharyngitis—Doxorubicin—stomach cancer	0.00073	0.00467	CcSEcCtD
Linagliptin—Infestation—Methotrexate—stomach cancer	0.000727	0.00465	CcSEcCtD
Linagliptin—Infestation NOS—Methotrexate—stomach cancer	0.000727	0.00465	CcSEcCtD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000713	0.00912	CbGpPWpGaD
Linagliptin—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000709	0.00453	CcSEcCtD
Linagliptin—Urticaria—Fluorouracil—stomach cancer	0.000708	0.00453	CcSEcCtD
Linagliptin—Weight increased—Epirubicin—stomach cancer	0.000694	0.00444	CcSEcCtD
Linagliptin—Pancreatitis—Doxorubicin—stomach cancer	0.000692	0.00443	CcSEcCtD
Linagliptin—Cough—Docetaxel—stomach cancer	0.000688	0.0044	CcSEcCtD
Linagliptin—Hypersensitivity—Irinotecan—stomach cancer	0.000686	0.00438	CcSEcCtD
Linagliptin—Infestation NOS—Epirubicin—stomach cancer	0.00068	0.00435	CcSEcCtD
Linagliptin—Infestation—Epirubicin—stomach cancer	0.00068	0.00435	CcSEcCtD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.000673	0.0086	CbGpPWpGaD
Linagliptin—Myalgia—Docetaxel—stomach cancer	0.000671	0.00429	CcSEcCtD
Linagliptin—Arthralgia—Docetaxel—stomach cancer	0.000671	0.00429	CcSEcCtD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—PLIN2—stomach cancer	0.000669	0.00856	CbGpPWpGaD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000666	0.00426	CcSEcCtD
Linagliptin—Cough—Capecitabine—stomach cancer	0.000666	0.00426	CcSEcCtD
Linagliptin—Urinary tract infection—Epirubicin—stomach cancer	0.000661	0.00423	CcSEcCtD
Linagliptin—Hypersensitivity—Fluorouracil—stomach cancer	0.000657	0.0042	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000656	0.0042	CcSEcCtD
Linagliptin—Arthralgia—Capecitabine—stomach cancer	0.00065	0.00415	CcSEcCtD
Linagliptin—Myalgia—Capecitabine—stomach cancer	0.00065	0.00415	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000645	0.00413	CcSEcCtD
Linagliptin—Anaphylactic shock—Docetaxel—stomach cancer	0.000643	0.00411	CcSEcCtD
Linagliptin—Weight increased—Doxorubicin—stomach cancer	0.000642	0.00411	CcSEcCtD
Linagliptin—Infection—Docetaxel—stomach cancer	0.000639	0.00409	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—EXOSC5—stomach cancer	0.000638	0.00816	CbGpPWpGaD
Linagliptin—Diarrhoea—Irinotecan—stomach cancer	0.000637	0.00407	CcSEcCtD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—NT5E—stomach cancer	0.000634	0.00811	CbGpPWpGaD
Linagliptin—Infestation NOS—Doxorubicin—stomach cancer	0.000629	0.00403	CcSEcCtD
Linagliptin—Infestation—Doxorubicin—stomach cancer	0.000629	0.00403	CcSEcCtD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000627	0.00802	CbGpPWpGaD
Linagliptin—Skin disorder—Docetaxel—stomach cancer	0.000625	0.004	CcSEcCtD
Linagliptin—Infection—Capecitabine—stomach cancer	0.000619	0.00396	CcSEcCtD
Linagliptin—Urinary tract infection—Doxorubicin—stomach cancer	0.000612	0.00391	CcSEcCtD
Linagliptin—Diarrhoea—Fluorouracil—stomach cancer	0.00061	0.0039	CcSEcCtD
Linagliptin—Skin disorder—Capecitabine—stomach cancer	0.000605	0.00387	CcSEcCtD
Linagliptin—Immune system disorder—Methotrexate—stomach cancer	0.000589	0.00377	CcSEcCtD
Linagliptin—Mediastinal disorder—Methotrexate—stomach cancer	0.000588	0.00376	CcSEcCtD
Linagliptin—ABCB1—lymph node—stomach cancer	0.000588	0.00777	CbGeAlD
Linagliptin—Rash—Irinotecan—stomach cancer	0.000587	0.00375	CcSEcCtD
Linagliptin—Dermatitis—Irinotecan—stomach cancer	0.000586	0.00375	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000586	0.00375	CcSEcCtD
Linagliptin—Headache—Irinotecan—stomach cancer	0.000583	0.00373	CcSEcCtD
Linagliptin—Malnutrition—Methotrexate—stomach cancer	0.000568	0.00363	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000567	0.00363	CcSEcCtD
Linagliptin—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000563	0.0072	CbGpPWpGaD
Linagliptin—Rash—Fluorouracil—stomach cancer	0.000562	0.00359	CcSEcCtD
Linagliptin—Dermatitis—Fluorouracil—stomach cancer	0.000561	0.00359	CcSEcCtD
Linagliptin—Headache—Fluorouracil—stomach cancer	0.000558	0.00357	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000555	0.00355	CcSEcCtD
Linagliptin—Immune system disorder—Epirubicin—stomach cancer	0.000552	0.00353	CcSEcCtD
Linagliptin—Mediastinal disorder—Epirubicin—stomach cancer	0.00055	0.00352	CcSEcCtD
Linagliptin—Constipation—Docetaxel—stomach cancer	0.00055	0.00352	CcSEcCtD
Linagliptin—Back pain—Methotrexate—stomach cancer	0.000549	0.00351	CcSEcCtD
Linagliptin—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.000541	0.00692	CbGpPWpGaD
Linagliptin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000538	0.00344	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—CDX2—stomach cancer	0.000537	0.00687	CbGpPWpGaD
Linagliptin—Constipation—Capecitabine—stomach cancer	0.000533	0.00341	CcSEcCtD
Linagliptin—Malnutrition—Epirubicin—stomach cancer	0.000532	0.0034	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—RPL18—stomach cancer	0.000527	0.00674	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—RPL13—stomach cancer	0.000527	0.00674	CbGpPWpGaD
Linagliptin—Back pain—Epirubicin—stomach cancer	0.000514	0.00329	CcSEcCtD
Linagliptin—Immune system disorder—Doxorubicin—stomach cancer	0.00051	0.00326	CcSEcCtD
Linagliptin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000509	0.00326	CcSEcCtD
Linagliptin—Cough—Methotrexate—stomach cancer	0.000496	0.00317	CcSEcCtD
Linagliptin—Urticaria—Capecitabine—stomach cancer	0.000495	0.00316	CcSEcCtD
Linagliptin—Malnutrition—Doxorubicin—stomach cancer	0.000492	0.00315	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—RPS21—stomach cancer	0.000492	0.00628	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—RPS15—stomach cancer	0.000492	0.00628	CbGpPWpGaD
Linagliptin—Arthralgia—Methotrexate—stomach cancer	0.000484	0.00309	CcSEcCtD
Linagliptin—Myalgia—Methotrexate—stomach cancer	0.000484	0.00309	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00048	0.00307	CcSEcCtD
Linagliptin—Back pain—Doxorubicin—stomach cancer	0.000476	0.00304	CcSEcCtD
Linagliptin—Hypersensitivity—Docetaxel—stomach cancer	0.000474	0.00303	CcSEcCtD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYT1—stomach cancer	0.000472	0.00604	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—RORA—stomach cancer	0.000469	0.006	CbGpPWpGaD
Linagliptin—Cough—Epirubicin—stomach cancer	0.000464	0.00297	CcSEcCtD
Linagliptin—Anaphylactic shock—Methotrexate—stomach cancer	0.000464	0.00296	CcSEcCtD
Linagliptin—Infection—Methotrexate—stomach cancer	0.000461	0.00295	CcSEcCtD
Linagliptin—Hypersensitivity—Capecitabine—stomach cancer	0.000459	0.00293	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—MUC2—stomach cancer	0.000457	0.00584	CbGpPWpGaD
Linagliptin—Arthralgia—Epirubicin—stomach cancer	0.000453	0.00289	CcSEcCtD
Linagliptin—Myalgia—Epirubicin—stomach cancer	0.000453	0.00289	CcSEcCtD
Linagliptin—Skin disorder—Methotrexate—stomach cancer	0.00045	0.00288	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000449	0.00287	CcSEcCtD
Linagliptin—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.000444	0.00567	CbGpPWpGaD
Linagliptin—Diarrhoea—Docetaxel—stomach cancer	0.00044	0.00281	CcSEcCtD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000439	0.00562	CbGpPWpGaD
Linagliptin—Anaphylactic shock—Epirubicin—stomach cancer	0.000434	0.00277	CcSEcCtD
Linagliptin—Infection—Epirubicin—stomach cancer	0.000431	0.00276	CcSEcCtD
Linagliptin—Cough—Doxorubicin—stomach cancer	0.000429	0.00274	CcSEcCtD
Linagliptin—Diarrhoea—Capecitabine—stomach cancer	0.000426	0.00272	CcSEcCtD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—NPM1—stomach cancer	0.000423	0.00541	CbGpPWpGaD
Linagliptin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000422	0.0027	CcSEcCtD
Linagliptin—Skin disorder—Epirubicin—stomach cancer	0.000421	0.00269	CcSEcCtD
Linagliptin—Myalgia—Doxorubicin—stomach cancer	0.000419	0.00268	CcSEcCtD
Linagliptin—Arthralgia—Doxorubicin—stomach cancer	0.000419	0.00268	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000416	0.00266	CcSEcCtD
Linagliptin—Rash—Docetaxel—stomach cancer	0.000406	0.00259	CcSEcCtD
Linagliptin—Dermatitis—Docetaxel—stomach cancer	0.000405	0.00259	CcSEcCtD
Linagliptin—Headache—Docetaxel—stomach cancer	0.000403	0.00258	CcSEcCtD
Linagliptin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000401	0.00257	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.0004	0.00256	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—RPL15—stomach cancer	0.000399	0.00511	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—HSPD1—stomach cancer	0.000399	0.00511	CbGpPWpGaD
Linagliptin—Infection—Doxorubicin—stomach cancer	0.000399	0.00255	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000395	0.00253	CcSEcCtD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—stomach cancer	0.000395	0.00505	CbGpPWpGaD
Linagliptin—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.000395	0.00505	CbGpPWpGaD
Linagliptin—Rash—Capecitabine—stomach cancer	0.000393	0.00251	CcSEcCtD
Linagliptin—Dermatitis—Capecitabine—stomach cancer	0.000392	0.00251	CcSEcCtD
Linagliptin—Headache—Capecitabine—stomach cancer	0.00039	0.00249	CcSEcCtD
Linagliptin—Skin disorder—Doxorubicin—stomach cancer	0.00039	0.00249	CcSEcCtD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000387	0.00494	CbGpPWpGaD
Linagliptin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000375	0.0024	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—RPS26—stomach cancer	0.000373	0.00476	CbGpPWpGaD
Linagliptin—Constipation—Epirubicin—stomach cancer	0.000371	0.00237	CcSEcCtD
Linagliptin—Urticaria—Methotrexate—stomach cancer	0.000368	0.00236	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000366	0.00234	CcSEcCtD
Linagliptin—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000358	0.00458	CbGpPWpGaD
Linagliptin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000347	0.00222	CcSEcCtD
Linagliptin—Urticaria—Epirubicin—stomach cancer	0.000345	0.0022	CcSEcCtD
Linagliptin—Constipation—Doxorubicin—stomach cancer	0.000343	0.0022	CcSEcCtD
Linagliptin—Hypersensitivity—Methotrexate—stomach cancer	0.000342	0.00218	CcSEcCtD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	0.000341	0.00436	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—IGFBP3—stomach cancer	0.000337	0.00432	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—ENO1—stomach cancer	0.000333	0.00426	CbGpPWpGaD
Linagliptin—Hypersensitivity—Epirubicin—stomach cancer	0.00032	0.00204	CcSEcCtD
Linagliptin—Urticaria—Doxorubicin—stomach cancer	0.000319	0.00204	CcSEcCtD
Linagliptin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000318	0.00406	CbGpPWpGaD
Linagliptin—Diarrhoea—Methotrexate—stomach cancer	0.000317	0.00203	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—RPS19—stomach cancer	0.000317	0.00405	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—PAX6—stomach cancer	0.000313	0.00401	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—APOA1—stomach cancer	0.000299	0.00383	CbGpPWpGaD
Linagliptin—Diarrhoea—Epirubicin—stomach cancer	0.000297	0.0019	CcSEcCtD
Linagliptin—Hypersensitivity—Doxorubicin—stomach cancer	0.000296	0.00189	CcSEcCtD
Linagliptin—Rash—Methotrexate—stomach cancer	0.000292	0.00187	CcSEcCtD
Linagliptin—Dermatitis—Methotrexate—stomach cancer	0.000292	0.00187	CcSEcCtD
Linagliptin—Headache—Methotrexate—stomach cancer	0.00029	0.00186	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—RPS6—stomach cancer	0.00028	0.00358	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ACE—stomach cancer	0.000278	0.00355	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000276	0.00353	CbGpPWpGaD
Linagliptin—Diarrhoea—Doxorubicin—stomach cancer	0.000275	0.00176	CcSEcCtD
Linagliptin—Rash—Epirubicin—stomach cancer	0.000274	0.00175	CcSEcCtD
Linagliptin—Dermatitis—Epirubicin—stomach cancer	0.000273	0.00175	CcSEcCtD
Linagliptin—Headache—Epirubicin—stomach cancer	0.000272	0.00174	CcSEcCtD
Linagliptin—Rash—Doxorubicin—stomach cancer	0.000253	0.00162	CcSEcCtD
Linagliptin—Dermatitis—Doxorubicin—stomach cancer	0.000253	0.00162	CcSEcCtD
Linagliptin—Headache—Doxorubicin—stomach cancer	0.000251	0.00161	CcSEcCtD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—stomach cancer	0.000243	0.00311	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000234	0.00299	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—stomach cancer	0.000233	0.00298	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000231	0.00295	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	0.000223	0.00285	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00021	0.00269	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	0.000205	0.00263	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	0.000205	0.00263	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL10—stomach cancer	0.000196	0.00251	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.00019	0.00242	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.000179	0.00229	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.00017	0.00217	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000156	0.00199	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	0.000154	0.00196	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	0.000146	0.00187	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.00014	0.00179	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—MMP2—stomach cancer	0.000138	0.00177	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CASP8—stomach cancer	0.000136	0.00173	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	0.000133	0.0017	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	0.000122	0.00155	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	0.000117	0.0015	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	0.000115	0.00147	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—CXCL8—stomach cancer	0.000115	0.00147	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CXCL8—stomach cancer	0.000107	0.00137	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL1B—stomach cancer	0.000103	0.00132	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000102	0.0013	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.000101	0.0013	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000101	0.00129	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	0.000101	0.00129	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	9.97e-05	0.00128	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ACAD8—stomach cancer	9.85e-05	0.00126	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	9.8e-05	0.00125	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	9.66e-05	0.00123	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	9.15e-05	0.00117	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GMPR2—stomach cancer	8.78e-05	0.00112	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—VEGFA—stomach cancer	8.71e-05	0.00111	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SUCLG1—stomach cancer	8.03e-05	0.00103	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—IDH3B—stomach cancer	8.03e-05	0.00103	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	7.64e-05	0.000977	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TNF—stomach cancer	7.47e-05	0.000955	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NDUFV1—stomach cancer	7.47e-05	0.000954	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NDUFS1—stomach cancer	7.47e-05	0.000954	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	7.19e-05	0.000919	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTP1—stomach cancer	7.06e-05	0.000903	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	6.96e-05	0.00089	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	6.7e-05	0.000856	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PGLS—stomach cancer	6.65e-05	0.000851	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—BLVRB—stomach cancer	6.65e-05	0.000851	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTM1—stomach cancer	6.49e-05	0.000829	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	6.4e-05	0.000818	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPAP2A—stomach cancer	6.35e-05	0.000812	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ACAD8—stomach cancer	6.07e-05	0.000776	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CKB—stomach cancer	5.66e-05	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CA1—stomach cancer	5.66e-05	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FBP1—stomach cancer	5.66e-05	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NDUFA2—stomach cancer	5.66e-05	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	5.58e-05	0.000714	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	5.46e-05	0.000698	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GMPR2—stomach cancer	5.41e-05	0.000692	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLIN2—stomach cancer	5.32e-05	0.00068	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CA2—stomach cancer	5.17e-05	0.000662	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	5.17e-05	0.000661	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NT5E—stomach cancer	5.04e-05	0.000645	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PGAM1—stomach cancer	5.04e-05	0.000645	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.95e-05	0.000633	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—IDH3B—stomach cancer	4.95e-05	0.000633	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	4.93e-05	0.000631	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	4.92e-05	0.000629	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDH7A1—stomach cancer	4.81e-05	0.000615	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLCE1—stomach cancer	4.81e-05	0.000615	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	4.77e-05	0.00061	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	4.66e-05	0.000595	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—UMPS—stomach cancer	4.61e-05	0.00059	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NDUFV1—stomach cancer	4.6e-05	0.000588	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NDUFS1—stomach cancer	4.6e-05	0.000588	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.3e-05	0.00055	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PDHA1—stomach cancer	4.29e-05	0.000548	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ECHS1—stomach cancer	4.29e-05	0.000548	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.13e-05	0.000528	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PGLS—stomach cancer	4.1e-05	0.000524	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—BLVRB—stomach cancer	4.1e-05	0.000524	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.07e-05	0.00052	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FADS1—stomach cancer	4.03e-05	0.000515	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TYMP—stomach cancer	4.03e-05	0.000515	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	3.96e-05	0.000506	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.91e-05	0.0005	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	3.87e-05	0.000495	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	3.87e-05	0.000495	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SREBF2—stomach cancer	3.77e-05	0.000483	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—RORA—stomach cancer	3.73e-05	0.000477	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	3.69e-05	0.000471	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	3.66e-05	0.000467	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDOB—stomach cancer	3.5e-05	0.000447	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FBP1—stomach cancer	3.49e-05	0.000446	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CA1—stomach cancer	3.49e-05	0.000446	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CKB—stomach cancer	3.49e-05	0.000446	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.49e-05	0.000446	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.36e-05	0.000429	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLIN2—stomach cancer	3.28e-05	0.000419	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALOX5—stomach cancer	3.25e-05	0.000415	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.25e-05	0.000415	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—DPYD—stomach cancer	3.2e-05	0.000409	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CA2—stomach cancer	3.19e-05	0.000408	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.13e-05	0.0004	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NT5E—stomach cancer	3.11e-05	0.000397	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PGAM1—stomach cancer	3.11e-05	0.000397	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLCE1—stomach cancer	2.96e-05	0.000379	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.96e-05	0.000379	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UMPS—stomach cancer	2.84e-05	0.000363	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTT1—stomach cancer	2.83e-05	0.000361	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2A6—stomach cancer	2.79e-05	0.000357	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKR1C3—stomach cancer	2.72e-05	0.000348	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ENO1—stomach cancer	2.65e-05	0.000339	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PDHA1—stomach cancer	2.64e-05	0.000338	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ECHS1—stomach cancer	2.64e-05	0.000338	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FADS1—stomach cancer	2.48e-05	0.000318	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TYMP—stomach cancer	2.48e-05	0.000318	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.48e-05	0.000317	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CD44—stomach cancer	2.35e-05	0.0003	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SREBF2—stomach cancer	2.33e-05	0.000297	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—RORA—stomach cancer	2.3e-05	0.000294	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDOB—stomach cancer	2.15e-05	0.000275	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALOX5—stomach cancer	2e-05	0.000256	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPP2R1A—stomach cancer	2e-05	0.000255	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—DPYD—stomach cancer	1.97e-05	0.000252	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTP1—stomach cancer	1.96e-05	0.000251	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMOX1—stomach cancer	1.93e-05	0.000247	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TYMS—stomach cancer	1.82e-05	0.000233	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTM1—stomach cancer	1.8e-05	0.00023	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTT1—stomach cancer	1.74e-05	0.000223	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.72e-05	0.00022	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ERCC2—stomach cancer	1.69e-05	0.000216	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.67e-05	0.000214	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ENO1—stomach cancer	1.63e-05	0.000209	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MTHFR—stomach cancer	1.59e-05	0.000203	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CAV1—stomach cancer	1.47e-05	0.000188	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA1—stomach cancer	1.46e-05	0.000187	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CD44—stomach cancer	1.45e-05	0.000185	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARG—stomach cancer	1.29e-05	0.000165	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.23e-05	0.000157	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTP1—stomach cancer	1.21e-05	0.000154	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMOX1—stomach cancer	1.19e-05	0.000152	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—stomach cancer	1.16e-05	0.000148	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TYMS—stomach cancer	1.12e-05	0.000143	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NOS3—stomach cancer	1.11e-05	0.000142	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTM1—stomach cancer	1.11e-05	0.000142	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ERCC2—stomach cancer	1.04e-05	0.000133	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—stomach cancer	1.02e-05	0.00013	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MTHFR—stomach cancer	9.8e-06	0.000125	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CAV1—stomach cancer	9.04e-06	0.000116	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA1—stomach cancer	9.02e-06	0.000115	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARG—stomach cancer	7.95e-06	0.000102	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—stomach cancer	7.15e-06	9.14e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NOS3—stomach cancer	6.84e-06	8.74e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—stomach cancer	6.25e-06	8e-05	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CA—stomach cancer	6.25e-06	7.99e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.85e-06	4.92e-05	CbGpPWpGaD
